Panntherapi won the L-Impact award for the Tech category and the Tech for Future award for the health category

Panntherapi finalizes its Seed funding with private individuals

Panntherapi moves to IPNP, French Institute of Psychiatry and Neurosciences of Paris.

The company is selected for the « Deeptech à fonds » program of BPI and the « Botech Booster » program of Business France.

Panntherapi is laureate of the 2021 i-Lab Innovation Competition.

The company was founded in March 2021 in France by a management team that has an extensive experience with biotech/ pharma companies and proven track-record in developing treatments for neurological and orphan diseases.

Panntherapi is incubated since December 2020 at Paris Biotech Santé (Paris) and BIC Innov’Up (Nîmes)

 PannTheraPi originates from PSL valorization of the work of Drs Nathalie Rouach, Elena Dossi and Gilles Huberfeld on pannexin channels using brain tissue from epileptic patients.